| Jenburkt Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524731 |
NSE Symbol : - |
P/E(TTM) : 14.57 |
|
ISIN Demat : INE354A01013 |
Div & Yield% : 1.65 |
EPS(TTM) : 74.77 |
|
Book Value(₹) : 414.39 |
Market Cap(₹Cr) : 480.85 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 45.56 | 35.53 | 41.05 | 36.89 | 41.22 | 32.54 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 45.56 | 35.53 | 41.05 | 36.89 | 41.22 | 32.54 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.08 | 2.06 | 1.88 | 1.58 | 1.85 | 1.41 |
| Total Income | 47.64 | 37.58 | 42.93 | 38.47 | 43.07 | 33.94 |
| Total Expenditure | 32.45 | 26.57 | 30.19 | 28.07 | 29.79 | 23.25 |
| PBIDT | 15.18 | 11.01 | 12.74 | 10.40 | 13.28 | 10.70 |
| Interest | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | 0.11 |
| PBDT | 15.08 | 10.90 | 12.63 | 10.29 | 13.16 | 10.58 |
| Depreciation | 0.74 | 0.72 | 0.79 | 0.78 | 0.64 | 0.52 |
| Tax | 4.00 | 2.00 | 3.58 | 3.00 | 3.00 | 2.50 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.17 | 0.39 | -0.28 | 0.01 | -0.08 | 0.15 |
| Reported Profit After Tax | 10.16 | 7.79 | 8.54 | 6.51 | 9.60 | 7.42 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 10.16 | 7.79 | 8.54 | 6.51 | 9.60 | 7.42 |
| EPS (Unit Curr.) | 23.03 | 17.66 | 19.34 | 14.75 | 21.75 | 16.80 |
| EPS (Adj) (Unit Curr.) | 23.03 | 17.66 | 19.34 | 14.75 | 21.75 | 16.80 |
| Calculated EPS (Unit Curr.) | 23.03 | 17.66 | 19.34 | 14.75 | 21.75 | 16.80 |
| Calculated EPS (Adj) (Unit Curr.) | 23.03 | 17.66 | 19.34 | 14.75 | 21.75 | 16.80 |
| Calculated EPS (Ann.) (Unit Curr.) | 92.12 | 70.62 | 77.37 | 58.98 | 87.01 | 67.22 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 92.12 | 70.62 | 77.37 | 58.98 | 87.01 | 67.22 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 4.41 | 4.41 | 4.41 | 4.41 | 4.41 | 4.41 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.32 | 30.99 | 31.04 | 28.19 | 32.22 | 32.88 |
| PBDTM(%) | 33.10 | 30.68 | 30.77 | 27.89 | 31.93 | 32.51 |
| PATM(%) | 22.30 | 21.93 | 20.80 | 17.65 | 23.29 | 22.80 |